Trial Outcomes & Findings for Combined Effect of Transcranial Direct Current Stimulation (tDCS) and Physical Activity on Gait and Functional Mobility in Participants With Multiple Sclerosis (NCT NCT03658668)

NCT ID: NCT03658668

Last Updated: 2023-08-16

Results Overview

Measured by a 10 meter walk test using wearable inertial sensors

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

23 participants

Primary outcome timeframe

Baseline, Follow-Up Visit (3 days after final treatment session, up to 4 weeks)

Results posted on

2023-08-16

Participant Flow

Participant milestones

Participant milestones
Measure
Active tDCS+PA
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Sham tDCS+PA
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Overall Study
STARTED
13
9
Overall Study
COMPLETED
12
8
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Active tDCS+PA
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Sham tDCS+PA
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Overall Study
Time Commitment
1
1

Baseline Characteristics

Combined Effect of Transcranial Direct Current Stimulation (tDCS) and Physical Activity on Gait and Functional Mobility in Participants With Multiple Sclerosis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active tDCS+PA
n=12 Participants
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Sham tDCS+PA
n=8 Participants
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Total
n=20 Participants
Total of all reporting groups
Age, Continuous
53.4 years
STANDARD_DEVIATION 12.3 • n=93 Participants
55 years
STANDARD_DEVIATION 7.55 • n=4 Participants
54.3 years
STANDARD_DEVIATION 10.3 • n=27 Participants
Sex: Female, Male
Female
8 Participants
n=93 Participants
6 Participants
n=4 Participants
14 Participants
n=27 Participants
Sex: Female, Male
Male
4 Participants
n=93 Participants
2 Participants
n=4 Participants
6 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
10 Participants
n=93 Participants
1 Participants
n=4 Participants
11 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
1 Participants
n=93 Participants
7 Participants
n=4 Participants
8 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Black or African American
3 Participants
n=93 Participants
2 Participants
n=4 Participants
5 Participants
n=27 Participants
Race (NIH/OMB)
White
8 Participants
n=93 Participants
6 Participants
n=4 Participants
14 Participants
n=27 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
Region of Enrollment
United States
12 participants
n=93 Participants
8 participants
n=4 Participants
20 participants
n=27 Participants

PRIMARY outcome

Timeframe: Baseline, Follow-Up Visit (3 days after final treatment session, up to 4 weeks)

Measured by a 10 meter walk test using wearable inertial sensors

Outcome measures

Outcome measures
Measure
Sham tDCS+PA
n=6 Participants
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Active tDCS+PA
n=9 Participants
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Change in Gait Velocity
0.01 meters/second (m/s)
Standard Deviation 0.33
0.33 meters/second (m/s)
Standard Deviation 0.32

PRIMARY outcome

Timeframe: Baseline, Follow-Up Visit (3 days after final treatment session, up to 4 weeks)

Measured by a 10 meter walk test using wearable inertial sensors

Outcome measures

Outcome measures
Measure
Sham tDCS+PA
n=6 Participants
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Active tDCS+PA
n=9 Participants
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Change in Stride Length
-0.02 meters (m)
Standard Deviation 0.2
0.32 meters (m)
Standard Deviation 0.17

SECONDARY outcome

Timeframe: End of Final Treatment Session (Up to Week 3)

Outcome measures

Outcome measures
Measure
Sham tDCS+PA
n=6 Participants
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Active tDCS+PA
n=9 Participants
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Percent of tDCS Sessions Completed
100 Percentage
Standard Deviation 0
100 Percentage
Standard Deviation 0

SECONDARY outcome

Timeframe: Baseline, Follow-Up Visit (3 days after final treatment session, up to 4 weeks)

12-item questionnaire assessing how multiple sclerosis (MS) affects walking abilities. Items are ranked on a scale from 1 (not at all) to 5 (extremely). The total score is the sum of responses and ranges from 12 to 60; higher scores indicate greater impact of MS on walking abilities.

Outcome measures

Outcome measures
Measure
Sham tDCS+PA
n=6 Participants
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Active tDCS+PA
n=9 Participants
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Change in 12-item Multiple Sclerosis Walking Scale Score
-2.5 score on a scale
Standard Deviation 2.9
-4.9 score on a scale
Standard Deviation 3.2

SECONDARY outcome

Timeframe: Baseline, Follow-Up Visit (3 days after final treatment session, up to 4 weeks)

21-item questionnaire assessing how fatigue may affect a person. Items are ranked on a scale from 0 (never) to 4 (almost always). The total score is the sum of responses and ranges from 0 to 84; scores indicate greater impact of fatigue.

Outcome measures

Outcome measures
Measure
Sham tDCS+PA
n=6 Participants
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Active tDCS+PA
n=9 Participants
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Change 21-item Modified Fatigue Impact Scale Score
1.6 score on a scale
Standard Deviation 8.7
-12.4 score on a scale
Standard Deviation 10.4

Adverse Events

Active tDCS+PA

Serious events: 0 serious events
Other events: 12 other events
Deaths: 0 deaths

Sham tDCS+PA

Serious events: 0 serious events
Other events: 9 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Active tDCS+PA
n=13 participants at risk
active tDCS: tDCS is a therapeutic treatment that utilizes low amplitude direct currents (\<4 mA) to induce changes in cortical excitability. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
Sham tDCS+PA
n=9 participants at risk
sham tDCS: During a sham session, the device is programmed to ramp up to the desired intensity (target 2.5 mA) and ramp down for the initial 60 seconds, with no current delivery during the session, and then again at the end of the session. These brief periods of stimulation serve to mimic the effects of a true stimulation session. Physical Activity (PA): 20 minutes of cycling on an ergonomic cross-trainer
General disorders
Tingling at the electrode site
76.9%
10/13 • 10 days
Standard questionnaire.
88.9%
8/9 • 10 days
Standard questionnaire.
General disorders
Itching at the electrode site
69.2%
9/13 • 10 days
Standard questionnaire.
66.7%
6/9 • 10 days
Standard questionnaire.
General disorders
Warmth Sensation at the electrode site
38.5%
5/13 • 10 days
Standard questionnaire.
44.4%
4/9 • 10 days
Standard questionnaire.

Additional Information

Mathew Lustberg, MA

NYU Langone Health

Phone: 929 445 5090

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place